🇺🇸 FDA
Patent

US 8741313

Polypeptide vaccine and vaccination strategy against mycobacterium

granted A61KA61K39/04A61P

Quick answer

US patent 8741313 (Polypeptide vaccine and vaccination strategy against mycobacterium) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon May 29 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Jun 03 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 29 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K39/04, A61P, A61P31/06